| Revision as of 05:39, 5 May 2010 editBogBot (talk | contribs)Bots53,132 editsm activated IUPHAR link← Previous edit | Revision as of 05:33, 13 May 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{chembox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (Next edit → | ||
| Line 1: | Line 1: | ||
| {{chembox | {{chembox | ||
| | verifiedrevid = 360226113 | |||
| |ImageFile=SCH_23390.svg | |ImageFile=SCH_23390.svg | ||
| |ImageSize=200px | |ImageSize=200px | ||
Revision as of 05:33, 13 May 2011
 | |
| Names | |
|---|---|
| IUPAC name 7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol | |
| Identifiers | |
| CAS Number | |
| 3D model (JSmol) | |
| IUPHAR/BPS | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
SMILES
| |
| Properties | |
| Chemical formula | C17H18ClNO |
| Molar mass | 287.78 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
 Y verify (what is ?)
Infobox references
| |
SCH23390 is a synthetic compound that acts as a D1 receptor antagonist and has either minimal or negligible effects on the D2 receptor.
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |